NCT01570972

Brief Summary

Multifamily group psychoeducation \[MFG\] and group cognitive behavioral therapy \[GCBT\] are evidence-based treatments for first episode psychosis. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experience a worsening of psychotic symptoms. Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could improve the clinical benefits facilitated by these two interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for not_applicable schizophrenia

Timeline
Completed

Started Feb 2010

Longer than P75 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

November 7, 2011

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 4, 2012

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

May 21, 2020

Status Verified

May 1, 2020

Enrollment Period

7.2 years

First QC Date

November 7, 2011

Last Update Submit

May 19, 2020

Conditions

Keywords

schizophreniaschizoaffective disorderbipolar disorder with psychotic featuresmajor depression with psychotic featuresrecent-onset psychosisfirst-episode psychosiscognitive behavioral therapymultifamily group psychoeducation

Outcome Measures

Primary Outcomes (6)

  • Change from baseline in General level of functioning at 6 months, 12 months, 18 months, and 24 months

    General level of functioning to be assessed using the General Assessment of Functioning (GAF) scale

    Baseline, 6 months, 12 months, 18 months, 24 months

  • Change from baseline in self-reported Physical Health at 6 months, 12 months, 18 months, and 24 months

    Self-reported physical health assessed using the RAND-36 Health Survey

    Baseline, 6 months, 12 months, 18 months, 24 months

  • Change from baseline in Social and vocational Functioning at 6 months, 12 months, 18 months, and 24 months

    Social and Vocational functioning to be assessed using the Social Functioning Scale

    Baseline, 6 months, 12 months, 18 months, 24 months

  • Change from baseline in Stage of Recovery at 6 months, 12 months, 18 months, and 24 months

    Stage of recovery assessed using the Stage of Recovery Instrument

    Baseline, 6 months, 12 months, 18 months, 24 months

  • Change from baseline Service Utilization at 6 months, 12 months, 18 months, and 24 months

    Service utilization as assessed using the Service Utilization Record Form

    Baseline, 6 months, 12 months, 18 months, 24 months

  • Change from Baseline Quality of Life at 6 months, 12 months, 18 months, and 24 months

    Quality of Life as assessed using the WHO Quality of Life Scale Brief

    Baseline, 6 months, 12 months, 18 months, 24 months

Study Arms (1)

MFG and GCBT

OTHER

There is a single arm for this study. All participants will be able to participate in MFG and GCBT

Behavioral: Group Cognitive Behavioral TherapyBehavioral: Multifamily Group Psychoeducation

Interventions

weekly

MFG and GCBT

twice monthly

MFG and GCBT

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of a non-substance induced psychotic disorder (schizophrenia spectrum or affective spectrum) per the Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revised (DSM-IV-TR) criteria determined using the Structured Clinical Interview for the DSM-IV.
  • Age between 18-35
  • Willing to participate in interventions at University of Arizona Medical Center South Campus
  • Willing to complete research assessments
  • Duration of psychotic symptoms of less than 5 years determined using the Symptom Onset in Schizophrenia inventory
  • Able to provide informed consent
  • Fluent in English
  • Willing to allow videotaping of group cognitive behavioral therapy sessions, multifamily group sessions, and family interaction task.
  • No evidence of mental retardation as defined as never having qualified to receive services from the Arizona Department of Economic Security, Division of Developmental Disabilities.
  • Must be someone that the individual with recent-onset psychosis identifies as providing support and care to the individual with recent-onset psychosis. Does not need to be a biological relative.
  • Must spend considerable time with the individual with recent-onset psychosis as defined at 10 hours or more of direct contact per week.
  • Willing to participate in participate in family intervention at University of Arizona Medical Center, South Campus for 2 years
  • Willing to complete research assessments
  • Able to provide informed consent
  • Fluent in English
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona Department of Psychiatry

Tucson, Arizona, 85724, United States

Location

Related Publications (3)

  • Moe AM, Wastler HM, Pine JG, Breitborde NJK. Metacognitive Skills Training and Computerized Cognitive Remediation among Individuals with First-Episode Psychosis: Influence on Social Cognition. Psychosis. 2023;15(4):418-423. doi: 10.1080/17522439.2022.2111595. Epub 2023 Jan 4.

  • Breitborde NJK, Bell EK, Woolverton C, Pine JG, Waslter H, Moe AM. Cost Utility of cognition-enhancing interventions for individuals with first-episode psychosis: a naturalistic evaluation. Cost Eff Resour Alloc. 2021 Jul 1;19(1):36. doi: 10.1186/s12962-021-00292-6.

  • Breitborde NJ, Bell EK, Dawley D, Woolverton C, Ceaser A, Waters AC, Dawson SC, Bismark AW, Polsinelli AJ, Bartolomeo L, Simmons J, Bernstein B, Harrison-Monroe P. The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service. BMC Psychiatry. 2015 Oct 28;15:266. doi: 10.1186/s12888-015-0650-3.

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Nicholas Breitborde, Ph.D.

    The Ohio State Univerity

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Department of Psychiatry

Study Record Dates

First Submitted

November 7, 2011

First Posted

April 4, 2012

Study Start

February 1, 2010

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

May 21, 2020

Record last verified: 2020-05

Locations